These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31654891)

  • 61. Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat® Inhaler in Patients with Chronic Obstructive Pulmonary Disease.
    Aalbers R; Maleki-Yazdi MR; Hamilton A; Waitere-Wijker S; Zhao Y; Amatto VC; Schmidt O; Bjermer L
    Adv Ther; 2015 Sep; 32(9):809-22. PubMed ID: 26404912
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies.
    Ferguson GT; Karpel J; Bennett N; Clerisme-Beaty E; Grönke L; Voß F; Buhl R
    NPJ Prim Care Respir Med; 2017 Feb; 27(1):7. PubMed ID: 28154373
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of switching tiotropium HandiHaler® to Respimat® Soft Mist™ Inhaler in patients with COPD: the difference of adverse events and usability between inhaler devices.
    Asakura Y; Nishimura N; Maezawa K; Terajima T; Kizu J; Chohnabayashi N
    J Aerosol Med Pulm Drug Deliv; 2013 Feb; 26(1):41-5. PubMed ID: 22691112
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of the addition of tiotropium on airway dimensions in symptomatic asthma.
    Hoshino M; Ohtawa J; Akitsu K
    Allergy Asthma Proc; 2016 Nov; 37(6):147-153. PubMed ID: 27931291
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
    Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A
    Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The efficacy and safety of tiotropium/olodaterol fixed-dose combination in Chinese patients with chronic obstructive pulmonary disease: a pooled subgroup analysis of TONADO 1+2].
    Bai CX; Tang Y; Xin JB; Li YL; Li ZK; Kang J; Huang JA; Xiao W; Wen ZG; Fu XH; He B; Liu CT; Chen P
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Nov; 42(11):838-844. PubMed ID: 31694094
    [No Abstract]   [Full Text] [Related]  

  • 67. Safety, tolerability, and plasma exposure of tiotropium Respimat® in children and adults with cystic fibrosis.
    Konstan MW; Sharma A; Moroni-Zentgraf P; Wang F; Koker P
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):137-44. PubMed ID: 25380193
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tiotropium in the add-on treatment of asthma in adults: clinical trial evidence and experience.
    Vogelberg C
    Ther Adv Respir Dis; 2016 Dec; 10(6):525-533. PubMed ID: 27612491
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tiotropium + olodaterol shows clinically meaningful improvements in quality of life.
    Singh D; Ferguson GT; Bolitschek J; Grönke L; Hallmann C; Bennett N; Abrahams R; Schmidt O; Bjermer L
    Respir Med; 2015 Oct; 109(10):1312-9. PubMed ID: 26320402
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma.
    Bateman ED; Kornmann O; Schmidt P; Pivovarova A; Engel M; Fabbri LM
    J Allergy Clin Immunol; 2011 Aug; 128(2):315-22. PubMed ID: 21807250
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonists.
    Willson J; Bateman ED; Pavord I; Lloyd A; Krivasi T; Esser D
    Appl Health Econ Health Policy; 2014 Aug; 12(4):447-59. PubMed ID: 24974107
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tiotropium for the treatment of asthma: a drug safety evaluation.
    Kerstjens HA; O'Byrne PM
    Expert Opin Drug Saf; 2016 Aug; 15(8):1115-24. PubMed ID: 27279414
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients.
    Ichinose M; Fujimoto T; Fukuchi Y
    Respir Med; 2010 Feb; 104(2):228-36. PubMed ID: 19969446
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tiotropium Respimat inhaler and the risk of death in COPD.
    Wise RA; Anzueto A; Cotton D; Dahl R; Devins T; Disse B; Dusser D; Joseph E; Kattenbeck S; Koenen-Bergmann M; Pledger G; Calverley P;
    N Engl J Med; 2013 Oct; 369(16):1491-501. PubMed ID: 23992515
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tiotropium as an add-on treatment to inhaled corticosteroids in children with severe and mild symptomatic asthma: Multi-center observational study for efficacy and safety analysis.
    Aierken A; Yu Su Fu BWMEM; Xu P
    Exp Ther Med; 2022 Sep; 24(3):577. PubMed ID: 35949336
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β
    Bleecker ER; FitzGerald JM; Chanez P; Papi A; Weinstein SF; Barker P; Sproule S; Gilmartin G; Aurivillius M; Werkström V; Goldman M;
    Lancet; 2016 Oct; 388(10056):2115-2127. PubMed ID: 27609408
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Safety of tiotropium in patients with asthma.
    Dusser D; Ducharme FM
    Ther Adv Respir Dis; 2019; 13():1753466618824010. PubMed ID: 30795731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.